Distribution of Candida species among bloodstream isolates

Saudi Medical Journal

Volumn 25, Issue 5, 2004, Pages 566-569

  Al Jasser, Asma M ^a   Elkhizzi, Noura A ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOW; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROBIOLOGY; PEDIATRICS; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SAUDI ARABIA; SURGICAL WARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; SAUDI ARABIA;

EID: 2942635476     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pfaller MA, Diekma DJ, Jones RN, Sader HS, Fluit S, Hollis AC et al. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibility to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254-32549.
2. Wey SB, Mori M, Pfaller MA, Wodson RF, Wenzel RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1998; 148: 2642-2645.
3. Wey SB, Mori M, Pfaller MA, Wodson RF, Wenzel RP. Risk factors for hospital acquired candidemia. Arch Intern Med 1989; 149: 2349-2353.
4. Blumberg HM, Jarvi WR, Soucie JM, Edward JE, Patterson JE, Pfaller MA et al. Risk factors for candidal bloodstream infection in surgical intensive care unit patients: The NEMIS prospective multicentre study. Clin Infect Dis 2001; 33: 177-186.
5. Akbar DH, Tahawi AT. Candidemia at a university hospital: epidemiology, risk factors and predictors of mortality. Annals of Saudi Medicine 2001; 21: 178-182.
6. Al-Hedaithy SS. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia. Mycoses 2003; 46: 293-298.
7. Osoba AO, Al-Mowallad, McAlear DE, Hussein BA. Candidemia and the susceptibility pattern of Candida isolates in blood. Saudi Med J 2003; 24: 1060-1063.
8. Bukharie HA. Nosocomial candidemia in a tertiary hospital in Saudi Arabia. Mycopathologia 2002; 41: 1907-1911.
9. Jarvis WR. Epidemiology of nosocomial fungal infection, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-1530.
10. Kremery V, Barnes AJ. Non-albicans candida spp. causing fungemia. Pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-260.
11. Perea S, Patterson TF. Antifungal resistance in pathogenic fungi. Clin Infect Dis 2002, 35: 1073-1080.
12. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinald M et al. National epidemiology of mycoses survey (NEMIS): variation in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253-258.
13. Trick WE, Fridkin SK, Edwards JR, Hajjch RA, Gayness RP. Secular trend of hospital - acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-630.
14. Lecciones JA, Lee JW, Navarro EE. Vascular Catheter-associated fungemia in patients with cancer: analysis of 150 episodes. Clin infect Dis 1992; 14: 875-884.
15. Stannard VA, Hutchinson A, Morris DL. Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med 1996; 22: 1339-1344.
16. Eickohoff TC. Antibiotic and nosocomial infections. In: Bennett JV, Branchman PS, editors. Hospital infections. 3rd ed. Boston (MA): Little, Brown and Co; 1992. p. 245-264.
17. Knotoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R et al. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 2001; 33: 1676-1681.
18. Levy I, Rubin LG, Vasishtha S, Tucci V, Soodk S. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin infect Dis 1998; 26: 1086-1088.
19. Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 1994; 41: 245-310.
20. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karpe JE, Saral R. Increase in Candida krusei among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-1277.
21. Safadar A, Chaturvedi V, Koill BS, Larone DH, Perlin DS, Armstrong D. Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida susceptibility trends study, 1998 to 1999) Antimicrob Agents Chemother 2002; 46: 3268-3272.